Experimental Alzheimer’s Drug Said to Succeed in Slowing Cognitive Decline
An experimental Alzheimer’s drug developed by Eisai and Biogen significantly slowed cognitive and functional decline in a large trial of patients in the early stages of the disease, the companies
Read More